• Overview
  • News
  • Analysis
  • Recos
  • Financials
  • Technicals
  • Peers
  • Shareholdings
  • MF
  • Corp Actions
  • About

Insights

View All

  • Meeting Agenda: Quarterly Results. Please add to watchlist to track closely.

  • Company has spent less than 1% of its operating revenues towards interest expenses and 13.64% towards employee cost in the year ending Mar 31, 2021. (Source: Consolidated Financials)

  • Company has used Rs 20.2 cr for investing activities which is an YoY increase of 40.84%. (Source: Consolidated Financials)

InsightsWindlas Biotech Ltd.

  • Board Meeting on Sep 8, 2021

    Meeting Agenda: Quarterly Results. Please add to watchlist to track closely.

  • Employee & Interest Expense

    Company has spent less than 1% of its operating revenues towards interest expenses and 13.64% towards employee cost in the year ending Mar 31, 2021. (Source: Consolidated Financials)

  • Increase in Cash from Investing

    Company has used Rs 20.2 cr for investing activities which is an YoY increase of 40.84%. (Source: Consolidated Financials)

Do you find these insights useful?

  • hate it

  • meh

  • love it

Key Metrics

  • -
  • 0.00
  • 870.36
  • 23
  • 4.00
  • 0.00
  • 5.00
  • -
  • 400.24

Returns

  • 1 Day0.58%
  • 1 Week15.78%
  • 1 MonthN.A.
  • 3 MonthsN.A.
  • 1 YearN.A.
  • 3 YearsN.A.
  • 5 YearsN.A.

Windlas Biotech Ltd. Stock Analysis

EARNINGS
FUNDAMENTAL
RELATIVE VALUATION
RISK
PRICE MOMENTUM

NO RATING (NR)

NEGATIVE (1-3)

NEUTRAL (4-7)

POSITIVE (8-10)

In-depth Reports on 4000+ Indian Stocks worth ₹1,499 with ET Prime membership

START FREE TRIAL

Recommendations

Financials

  • Income (P&L)

  • Balance Sheet

  • Cash Flow

  • Ratios

  • Insights

    • Employee & Interest Expense

      Company has spent less than 1% of its operating revenues towards interest expenses and 13.64% towards employee cost in the year ending Mar 31, 2021. (Source: Consolidated Financials)
    Annual FY 2021 FY 2020
    Total Revenue430.70331.34
    Total Revenue Growth (%)29.996.36
    Total Expenses387.17299.21
    Total Expenses Growth (%)29.405.28
    Profit after Tax (PAT)15.8316.21
    PAT Growth (%)-2.35-74.60
    Operating Profit Margin (%)10.4810.53
    Net Profit Margin (%)3.704.93
    Basic EPS (₹)8.708.90
    Annual FY 2020
    Total Revenue329.81
    Total Revenue Growth (%)13.60
    Total Expenses299.24
    Total Expenses Growth (%)17.14
    Profit after Tax (PAT)22.46
    PAT Growth (%)-0.06
    Operating Profit Margin (%)10.01
    Net Profit Margin (%)6.82
    Basic EPS (₹)35.03

    All figures in Rs Cr, unless mentioned otherwise

    No reported Profit & Loss Statement are available.

  • Annual FY 2021 FY 2020
    Total Assets296.12338.49
    Total Assets Growth (%)-12.5213.52
    Total Liabilities97.00128.83
    Total Liabilities Growth (%)-24.7023.17
    Total Equity199.12209.66
    Total Equity Growth (%)-5.038.30
    Current Ratio (x)2.081.34
    Total Debt to Equity (x)0.150.11
    Contingent Liabilities--
    Annual FY 2020
    Total Assets343.80
    Total Assets Growth (%)15.75
    Total Liabilities127.32
    Total Liabilities Growth (%)23.62
    Total Equity216.48
    Total Equity Growth (%)11.58
    Current Ratio (x)1.30
    Total Debt to Equity (x)0.10
    Contingent Liabilities-

    All figures in Rs Cr, unless mentioned otherwise

  • Insights

    • Cash from Operations vs PAT

      Operating cash flow of Rs 11.45 cr is 0.72 times compared to the reported net profit of Rs 15.83 cr. (Source: Consolidated Financials)
    • Increase in Cash from Investing

      Company has used Rs 20.2 cr for investing activities which is an YoY increase of 40.84%. (Source: Consolidated Financials)
    Annual FY 2021 FY 2020
    Net Cash flow from Operating Activities11.4525.01
    Net Cash used in Investing Activities-20.20-14.34
    Net Cash flow from Financing Activities0.78-5.44
    Net Cash Flow-2.155.22
    Closing Cash & Cash Equivalent15.9318.08
    Closing Cash & Cash Equivalent Growth (%)-11.8840.63
    Total Debt/ CFO (x)2.640.89
    Annual FY 2020
    Net Cash flow from Operating Activities20.88
    Net Cash used in Investing Activities-9.17
    Net Cash flow from Financing Activities-6.48
    Net Cash Flow5.22
    Closing Cash & Cash Equivalent18.08
    Closing Cash & Cash Equivalent Growth (%)40.63
    Total Debt/ CFO (x)1.06

    All figures in Rs Cr, unless mentioned otherwise

  • Annual FY 2021 FY 2020
    Return on Equity (%)7.957.73
    Return on Capital Employed (%)22.1116.25
    Return on Assets (%)5.344.78
    Interest Coverage Ratio (x)34.7413.72
    Asset Turnover Ratio (x)144.4097.15
    Price to Earnings (x)--
    Price to Book (x)--
    EV/EBITDA (x)--
    EBITDA Margin (%)13.5113.36
    Annual FY 2020
    Return on Equity (%)10.37
    Return on Capital Employed (%)15.05
    Return on Assets (%)6.53
    Interest Coverage Ratio (x)13.91
    Asset Turnover Ratio (x)95.65
    Price to Earnings (x)-
    Price to Book (x)-
    EV/EBITDA (x)-
    EBITDA Margin (%)12.65

Financial InsightsWindlas Biotech Ltd.

  • Income (P&L)
  • Cash Flow
    • Employee & Interest Expense

      Company has spent less than 1% of its operating revenues towards interest expenses and 13.64% towards employee cost in the year ending Mar 31, 2021. (Source: Consolidated Financials)

    • Cash from Operations vs PAT

      Operating cash flow of Rs 11.45 cr is 0.72 times compared to the reported net profit of Rs 15.83 cr. (Source: Consolidated Financials)

    • Increase in Cash from Investing

      Company has used Rs 20.2 cr for investing activities which is an YoY increase of 40.84%. (Source: Consolidated Financials)

Do you find these insights useful?

  • hate it

  • meh

  • love it

Technicals

  • Buy / Sell Signals

  • Price Analysis

  • Pivot Levels & ATR

  • Chart

  • Stock doesnt have any Buy/Sell Signals.

  • Price Analysis Data details are not available.

  • Pivot Levels

    R1R2R3PIVOTS1S2S3
    Classic-------

    Average True Range

    5 DAYS14 DAYS28 DAYS
    ATR---

Peer Comparison

  • Stock Performance

  • Ratio Performance

    • CHART
    • TABLE
    • There’s no suggested peer for this stock.
    • 1D
    • 1W
    • 1M
    • 3M
    • 6M
    • 1Y
    • 5Y
  • Ratio Performance

    NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
    Windlas Biotech Ltd.0.004.0210.3715.056.530.0010.016.8235.031.300.101.06
    Add More stocks of your interest to compare.

    Annual Ratios (%)

    See All Parameters

Peers InsightsWindlas Biotech Ltd.

Do you find these insights useful?

  • hate it

  • meh

  • love it

Shareholding Pattern

Shareholding details are not available.

MF Ownership

MF Ownership details are not available.

Top Searches:

Corporate Actions

  • Board Meeting/AGM

  • Dividends

  • Others
  • Meeting DateAnnounced onPurposeDetails
    Sep 08, 2021Aug 25, 2021Board MeetingQuarterly Results
  • Dividend announcements are not available.

  • No other corporate actions details are available.

About Windlas Biotech Ltd.

Windlas Biotech Ltd., incorporated in the year 2001, is a Small Cap company (having a market cap of Rs 873.08 Crore) operating in General sector. Windlas Biotech Ltd. key Products/Revenue Segments include Pharmaceuticals, Export Incentives, Sale of services, Other Operating Revenue and Scrap for the year ending 31-Mar-2020. Show More

  • Executives

  • Auditors

  • VD

    Vivek Dhariwal

    Chairman(NonExe.&Ind.Director)

    HW

    Hitesh Windlass

    Managing Director

    MK

    Manoj Kumar Windlass

    Joint Managing Director

    AK

    Ashok Kumar Windlass

    Whole Time Director

    Show More

Address

40/1, Mohabewala Industrial Area,Dehradun, Uttaranchal - 248110

More Details

Windlas Biotech Ltd. Share Price Update

Windlas Biotech Ltd. share price moved up by 0.84% from its previous close of Rs 396.85. Windlas Biotech Ltd. stock last traded price is 400.20

Share PriceValue
Today/Current/Last400.20
Previous Day396.85

Trending in Markets

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.

Contact us

Find us at the office

Trailor- Verkamp street no. 63, 81415 Zagreb, Croatia

Give us a ring

Dezha Manci
+38 695 645 231
Mon - Fri, 8:00-22:00

Reach out